Is this medication very expensive?
Dosage of Cardimax - SR in details
1 tablet of Cardimax - SR twice daily during meals.
Renal Impairment: In patients with moderate renal impairment (creatinine clearance 30-60 mL/min), the recommended dose is 1 tablet Cardimax - SR in the morning during breakfast.
Elderly: Elderly patients may have increased Cardimax - SR exposure due to age-related decrease in renal function. In patients with moderate renal impairment (creatinine clearance 30-60 mL/min), the recommended dose is 1 tablet Cardimax - SR in the morning during breakfast.
Dose titration in elderly patients should be exercised with caution.
Children: The safety and efficacy of Cardimax - SR in children <18 years have not been established. No data are available.
Cardimax - SR interactions
Sympatholytics, nifedipine, nitroglycerin, diuretics, hydralazine and other antihypertensive drugs potentiate hypotension.
Antiarrhythmic and anesthetic medications increase the risk of bradycardia, arrhythmia, hypotension.
Digitalis drugs potentiate slowing AV conduction.
Simultaneously intravenous injection of verapamil and diltiazem may cause cardiac arrest.
Beta-adrenoceptor agonists, aminophylline, cocaine, estrogens, indomethacin and other NSAIDs impair antihypertensive effect.
Cardimax - SR Interhealthcare Pharmaceuticals enhances and prolongs the action of anti depolarizing muscle relaxants.
Combination with alcohol leads to mutual reinforcement of inhibitory effects on the CNS.
Allergens increased the risk of severe systemic allergic reactions or anaphylaxis.
Metoprolol edits the effectiveness of insulin and oral antidiabetic drugs and increases the risk of hypoglycemia.
Oral contraceptives, cimetidine, ranitidine, phenothiazines raise the level of this drug in the blood, rifampicin decreases it.
Cardimax - SR Interhealthcare Pharmaceuticals reduces the clearance of lidocaine, the effectiveness of beta 2-agonists (it is necessary to increase the dose of the latter).
This medicine is incompatible with MAO inhibitors of type A.
- FDA/SPL Indexing Data. "N9A0A0R9S8: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
- MeSH. "Vasodilator Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
- European Chemicals Agency - ECHA. "Trimetazidine: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
ReviewsThe results of a survey conducted on ndrugs.com for Cardimax - SR are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Cardimax - SR. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported frequency of useNo survey data has been collected yet
Consumer reported dosesNo survey data has been collected yet
There are no reviews yet. Be the first to write one!
Information checked by Dr. Sachin Kumar, MD Pharmacology